Publicaciones (379) Publicaciones de JORGE MATÍAS-GUIU GUÍA

2024

  1. A data-driven approach to complement the A/T/(N) classification system using CSF biomarkers

    CNS Neuroscience and Therapeutics, Vol. 30, Núm. 2

  2. Cognitive dysfunction characteristics of multiple sclerosis with aging

    Multiple Sclerosis and Related Disorders, Vol. 87

  3. Cognitive profile in multiple sclerosis and post-COVID condition: a comparative study using a unified taxonomy

    Scientific Reports, Vol. 14, Núm. 1

  4. Comparison of the Diagnostic Accuracy of Five Cognitive Screening Tests for Diagnosing Mild Cognitive Impairment in Patients Consulting for Memory Loss

    Journal of Clinical Medicine, Vol. 13, Núm. 16

  5. Conversion between the Rowland Universal Dementia Assessment Scale and Mini-Mental State Examination test scores in majority and minority populations

    Brain and Behavior, Vol. 14, Núm. 9

  6. Correction to: Genetic-based patient stratification in Alzheimer’s disease (Scientific Reports, (2024), 14, 1, (9970), 10.1038/s41598-024-60707-1)

    Scientific Reports

  7. Deep Learning For Predicting Cerebral Metabolism Changes Along The Alzheimer’s Disease Continuum

    Proceedings IMCIC - International Multi-Conference on Complexity, Informatics and Cybernetics

  8. Detection of cerebrospinal fluid biomarkers changes of Alzheimer’s disease using a cognitive stress test in persons with subjective cognitive decline and mild cognitive impairment

    Frontiers in Psychology, Vol. 15

  9. European cross-cultural neuropsychological test battery (CNTB) for the assessment of cognitive impairment in multiple sclerosis: Cognitive phenotyping and classification supported by machine learning techniques

    Multiple Sclerosis and Related Disorders, Vol. 91

  10. Genetic-based patient stratification in Alzheimer’s disease

    Scientific Reports, Vol. 14, Núm. 1

  11. In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use

    Translational Neurodegeneration, Vol. 13, Núm. 1

  12. Leptin haploinsufficiency exerts sex-dependent partial protection in SOD1G93A mice by reducing inflammatory pathways in the adipose tissue

    Scientific Reports, Vol. 14, Núm. 1

  13. Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities

    Biomolecules, Vol. 14, Núm. 1

  14. Murine experimental models of amyotrophic lateral sclerosis: An update

    Neurologia, Vol. 39, Núm. 3, pp. 282-291

  15. Neural basis of fatigue in post-COVID syndrome and relationships with cognitive complaints and cognition

    Psychiatry Research, Vol. 340

  16. Pilot Trial on Awake Surgery for Low-Grade Arteriovenous Malformations in Speech Area and Systematic Review of the Literature

    World Neurosurgery, Vol. 189, pp. 154-160

  17. Predicting changes in brain metabolism and progression from mild cognitive impairment to dementia using multitask Deep Learning models and explainable AI

    NeuroImage, Vol. 297

  18. Thermosensitive chitosan-based hydrogel: A vehicle for overcoming the limitations of nose-to-brain cell therapy

    Acta Biomaterialia, Vol. 188, pp. 157-168

2023

  1. A proposed new taxonomy of cognitive phenotypes in multiple sclerosis: The International Classification of Cognitive Disorders in MS (IC-CoDiMS)

    Multiple Sclerosis Journal, Vol. 29, Núm. 4-5, pp. 615-627

  2. A review of novel Cognitive Challenge Tests for the assessment of preclinical Alzheimer's disease

    Neuropsychology, Vol. 37, Núm. 6, pp. 661-672